Research

Mixed

Cholesterol-lowering therapy with atorvastatin completely prevents NAFLD-HCC development in high-cholesterol diet-fed mice by restoring gut microbiota dysbiosis.

For patients with fatty liver and high cholesterol, statin therapy may offer protection against liver cancer by normalizing gut bacteria. This suggests that managing cholesterol with statins might have benefits beyond cardiovascular health for liver cancer prevention.

GoodSupportsHIGH confidence
Moreover, atorvastatin restored cholesterol- induced gut microbiota dysbiosis and completely prevented NAFLD–HCC development.
Xiang Zhang et al. · Gut · 2020

Why this rating

Strong efficacy in animal models with clear mechanistic link to microbiota restoration.

Source

Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites

Xiang Zhang et al. · Gut · 2020

DOI 10.1136/gutjnl-2019-319664

mechanism_only · n=98Cited 843×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →